Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii.
about
Induced Bacterial Cross-Resistance toward Host Antimicrobial Peptides: A Worrying PhenomenonInsect Antimicrobial Peptide Complexes Prevent Resistance Development in BacteriaColistin heteroresistance in Enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme.Adaptive evolution of Escherichia coli to an α-peptide/β-peptoid peptidomimetic induces stable resistance.Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens.Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria.OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii.Mechanisms of antimicrobial resistance in Gram-negative bacilli.Natural antimicrobial peptide complexes in the fighting of antibiotic resistant biofilms: Calliphora vicina medicinal maggots.In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate.The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii.Cathelicidin Antimicrobial Peptides with Reduced Activation of Toll-Like Receptor Signaling Have Potent Bactericidal Activity against Colistin-Resistant BacteriaLittle peptide, big effects: the role of LL-37 in inflammation and autoimmune diseaseCombination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date.Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains.Activity of host antimicrobials against multidrug-resistant Acinetobacter baumannii acquiring colistin resistance through loss of lipopolysaccharide.Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.Targeting the permeability barrier and peptidoglycan recycling pathways to disarm Pseudomonas aeruginosa against the innate immune system.Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance.Crystal structure of 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase from the ESKAPE pathogen Acinetobacter baumannii.Prospective, Randomized Comparison of the Effect of Two Antimicrobial Regimes on Surgical Site Infection Rate in Dogs Undergoing Orthopedic Implant Surgery.From bacterial killing to immune modulation: Recent insights into the functions of lysozyme.Peptide array based discovery of synthetic antimicrobial peptides.Re-evaluating the approach to drug target discovery in multidrug-resistant Gram-negative bacilli.MCR-1 Confers Cross-Resistance to Bacitracin, a Widely Used In-Feed Antibiotic
P2860
Q26752291-9400C017-8B87-443D-992C-FA04677DAF30Q28546527-22FD68E5-93EA-420C-8839-C286D4E83C66Q34057439-AE3C2D8E-8C68-4D49-8EFD-3C48EE565B96Q34989010-33876FF0-7A00-4287-BCAD-17DDAB24DEA6Q35105947-932E9F91-558D-45F8-AC86-518FBD2E02B8Q35541353-D6623184-9F04-4749-96AF-A632DD053405Q35814247-BE899402-2F09-407E-A196-80A5E09809A5Q35935319-95B853F8-FBE2-453D-890C-34E6297DCD87Q36302767-139A1B31-C553-4CB9-B7D5-D26DBF687DA3Q36893415-45E46316-1A83-486D-9643-6FFB80BCE100Q36956080-D199E638-D6F2-41DB-B07F-4BBDC6C125B3Q37270946-C574836C-9522-4F0B-979D-F25C391D4544Q37332300-5EA37CF2-C8B6-4864-8DEA-7ED9B71A2E70Q38232199-9F7A00A3-6EFB-4C96-BDD0-F6869188B35FQ38805792-3C1C79CC-F5BE-4D8C-B829-A3DDEFF9E3ACQ38849225-8551AC0B-0FB5-4FBA-AB3B-C45384735537Q39218893-ED4F5F27-141D-46FC-8B78-F56FBE42D8D6Q40120435-0B1CD42F-8D7D-4EBD-9270-84B7B219D3DFQ40306876-5E933F41-074C-4A43-A024-A6529CCF9CB7Q40776076-BE0DE9E9-8CA7-4243-AE08-76D59CBE291FQ41423168-6F4A5F39-CC85-415B-B4F6-2A131890D872Q42047981-00DE6D73-F982-420F-8079-C5180B2B608FQ42776890-35B87B1A-8A23-46DD-912B-708980328FA0Q48710014-679C2AD8-E4B2-4786-9FC3-F50A789CE911Q58763161-9F8B1F48-34F2-400F-B6F6-9D82A65620AE
P2860
Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Clinical use of colistin induc ...... ls in Acinetobacter baumannii.
@ast
Clinical use of colistin induc ...... ls in Acinetobacter baumannii.
@en
Clinical use of colistin induc ...... ls in Acinetobacter baumannii.
@nl
type
label
Clinical use of colistin induc ...... ls in Acinetobacter baumannii.
@ast
Clinical use of colistin induc ...... ls in Acinetobacter baumannii.
@en
Clinical use of colistin induc ...... ls in Acinetobacter baumannii.
@nl
prefLabel
Clinical use of colistin induc ...... ls in Acinetobacter baumannii.
@ast
Clinical use of colistin induc ...... ls in Acinetobacter baumannii.
@en
Clinical use of colistin induc ...... ls in Acinetobacter baumannii.
@nl
P2093
P2860
P356
P1433
P1476
Clinical use of colistin induc ...... ls in Acinetobacter baumannii.
@en
P2093
Brooke A Napier
David S Weiss
Eileen M Burd
Emil P Lesho
Patrick McGann
Sarah W Satola
Stephanie M Cagle
Susan M Ray
P2860
P304
P356
10.1128/MBIO.00021-13
P577
2013-05-21T00:00:00Z